Abstract
One of the tasks of andrology is to provide methods for contraception on the male side. Such methods are necessary both to maintain a stable population in industrialized countries and to contain population growth in developing countries. In this chapter, the rationale for male contraception as well as social and demographic aspects will be discussed and the conventional methods of male contraception will be described: condoms, coitus interruptus, and periodic abstinence. Chapter “Approaches to Hormonal Male Contraception” is devoted to vasectomy and refertilization. To date, a reversible pharmacological method is not available. Research and development in this field will be described in Chaps. “Nonhormonal Approaches to Male Contraception” and “Legal Regulations in Andrology and Reproductive Medicine.”
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Amy JJ, Thiery M (2015) The condom: a turbulent history. Eur J Contracept Reprod Health Care 20:387–402
Anderson RA, Baird DT (1997) Progress towards a male pill. IPPF Med Bull 31:1−5
Benagiano G, Bastianello C, Farris M (2007) Contraception: a social revolution. Europ Contracept Reprod Health Care 12:3–12
Bengtson T, Dribe M (2006) Deliberate control in a natural fertility population: southern Sweden, 1766–1864. Demography 43:727–746
Birg H (2001) Die demographische Zeitwende, 4th edn. C.H. Beck, München
Bongaarts J, O’Neill BC (2018) Global warming policy: is population left out in the cold? Science 361:650–652
Bongaarts J, Sitruk-Ware R (2019) Climate change and contraception. BMJ Sex Reprod Health 45:233–235
Bonnar J, Flynn A, Freundl G, Kirkman R, Royston R, Snowden R (1999) Personal hormone monitoring for contraception. Br J Fam Plann 24:128–134
Connelly M (2008) Fatal misconception: the struggle to control world population. Belknap Press of Harvard University Press, Cambridge, MA
Crist E, Mora C, Engelman R (2017) The interaction of human population, food production, and biodiversity protection. Science 356:260–264
Demir O, Ozalp M, Sal H, Aran T, Osmanagaoglu MA (2020) Evaluation of the frequency of coitus interruptus and the effect of contraception counselling on this frequency. J Obstet Gynaecol 16:1−6
Dorman E, Bishai D (2012) Demand for male contraception. Expert Rev Pharmacoecon Outcomes Res 12:605–613
Freundl G, Sivin I, Batár I (2010) State-of-the-art of non-hormonal methods of contraception: IV. Natural family planning. Eur J Contracept Reprod Health Care 15:113–123
Ganatra B, Gerdts C, Rossier C, Johnson BR Jr, Tunçalp Ö, Assifi A, Sedgh G, Singh S, Bankole A, Popinchalk A, Bearak J, Kang Z, Alkema L (2017) Global, regional, and subregional classification of abortions by safety, 2010–14: estimates from a Bayesian hierarchical model. Lancet 390:2372–2381
Hardee K, Croce-Galis M, Gay J (2017) Are men well served by family planning programs? Reprod Health 14:14
Heinemann K, Saad F, Wiesemes M, White S, Heinemann L (2005) Attitudes toward male fertility control: results of a multinational survey on four continents. Hum Reprod 20:549–556
Kriel Y, Milford C, Cordero J, Suleman F, Beksinska M, Steyn P, Smit JA (2019) Male partner influence on family planning and contraceptive use: perspectives from community members and healthcare providers in KwaZulu-Natal, South Africa. Reprod Health 16:89
Krishnaratne S, Hensen B, Cordes J, Enstone J, Hargreaves JR (2016) Interventions to strengthen the HIV prevention cascade: a systematic review of reviews. Lancet HIV 3:e307–e317
Nieschlag E (2007) 10th Summit Meeting consensus: recommendations for regulatory approval for hormonal male contraception. October 22–23, 2006. Contraception 75:166–167
Nieschlag E (2011) The struggle for male hormonal contraception. Best Pract Res Clin Endocrinol Metab 25:369–375
Nieschlag E (2013) Hormonal male contraception: end of a dream or start of a new era? Endocrine 43:535–538
Rosenberg MJ, Waugh MS (1997) Latex condom breakage and slippage in a controlled clinical trial. Contraception 56:17–21
Ross J, Hardee K (2017) Use of male methods of contraception worldwide. J Biosoc Sci 49:648–663
Serfaty D, Sitruk-Ware R, Wang C, Nieschlag E (2016) The Paris manifesto: It’s time for new male contraceptives. J Gynecol Obstet Biol Reprod (Paris) 45:990–991
Serfaty D, Sitruk-Ware R, Wang C, Nieschlag E, Swerdloff R (2018) The second Paris manifesto on male contraception: moving forward. Paris 7.5.2018. JRE 15:171–172
Strauss JF, Chaudhuri G (2007) The accelerated pace of pharma abandonment of research and development in family planning and fertility: will reproductive health technology be frozen in time? Fertil Steril 87:818–718
Trussell J (1998) Contraceptive efficacy. In: Hatcher RA, Trussell J, Stewart F (eds) Contraceptive technology Ardent Media. New York, pp. 779–844
United Nations, Department of Economic and Social Affairs (2019) Contraceptive use by method: Data Booklet
Wang C, Sitruk-Ware R, Serfaty D (2016) It is time for new male contraceptives! Andrology 4:773–775
WHO, UNFPA, FHI (2010) The male latex condom: specifications and guidelines for condom procurement. WHO, Geneva
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Nieschlag, E. (2023). Male Contribution to Contraception. In: Nieschlag, E., Behre, H.M., Kliesch, S., Nieschlag, S. (eds) Andrology. Springer, Cham. https://doi.org/10.1007/978-3-031-31574-9_45
Download citation
DOI: https://doi.org/10.1007/978-3-031-31574-9_45
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-31573-2
Online ISBN: 978-3-031-31574-9
eBook Packages: MedicineMedicine (R0)